Skip to Content

7113 (Docusate Sodium 250 mg)

Pill with imprint 7113 is Red, Capsule-shape and has been identified as Docusate Sodium 250 mg. It is supplied by Watson Pharmaceuticals.

Docusate is used in the treatment of constipation and belongs to the drug class laxatives. FDA has not classified the drug for risk during pregnancy. Docusate 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 7113

Docusate sodium 250 mg 7113

Docusate Sodium

Imprint
7113
Strength
250 mg
Color
Red
Size
20.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Laxatives
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00536-3757
Inactive Ingredients
FD&C Red No. 40, FD&C Yellow No. 6, gelatin, glycerin, polyethylene glycol, propylene glycol, water, sorbitol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "7113"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.